People | April 03, 2023
CBC Group appoints Abbas Hussain as Operating Partner
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
First launches expected in H1 2022
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
First and only therapy approved by the FDA for the treatment of pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis
Subscribe To Our Newsletter & Stay Updated
